Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach
Clémence Basse, Hédi Chabanol, Pierre‐Emmanuel Bonté, Isabelle Fromantin, Nicolas Girard
Topics & Concepts
MedicineBispecific antibodyLung cancerMultidisciplinary approachOncologyEpidermal growth factor receptorCancer researchInternal medicineAntibodyCancerImmunologyMonoclonal antibodySociologySocial scienceLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesFibroblast Growth Factor Research